— Know what they know.
Not Investment Advice

ETON NASDAQ

Eton Pharmaceuticals, Inc.
1W: -4.0% 1M: -10.7% 3M: +45.6% YTD: +240.5% 1Y: +173.2% 3Y: +1082.9% 5Y: +1005.0%
$55.36
+3.38 (+6.50%)
 
Weekly Expected Move ±9.5%
$45 $50 $55 $61 $66
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 42 · $1.5B mcap · 21M float · 2.58% daily turnover · Short 69% of daily vol

📊 Key Metrics

TTM
$106M
Revenue
+81.5% YoY
$13M
Net Income
+407.4% YoY
$15M
Free Cash Flow
+20.5% YoY
67.6%
Gross Margin
34.0%
Op. Margin
30.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE36.0%
ROA11.7%
ROIC33.3%

Valuation

P/E119.1
P/B32.8
EV/EBITDA64.1

Leverage

Debt/Equity0.62
Current Ratio1.52
Interest Cov.5.8x

Quality Scores

Piotroski F7/9
Altman Z10.68
Beneish M-1.66

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms